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Abstract
Objective: We examined a panel of cytokines and cell adhesion molecules in an 
attempt to identify cancer speciﬁc proﬁles.
Design and methods: Cytokines and cell adhesion arrays (Randox Ltd.) were 
measured in samples from women with a histological diagnosis of ovarian cancer 
(𝑛 = 42) or breast cancer (𝑛 = 60) or cancer free (𝑛 = 32). Random forest analysis 
was used for classiﬁcation.
Results: Ovarian cancer subjects were classiﬁed with a sensitivity of 85.7% 
(95% CI 50–100) and a speciﬁcity of 84.2% (95% CI 69.4–93.4). Breast cancer 
subjects were classiﬁed with a sensitivity of 70.8% (95% CI 47.1–86.4) and a 
speciﬁcity of 96.4% (95% CI 82.1–100).
Discussion: Cytokine and cell adhesion molecule proﬁles provide additional 
information that may be useful for cancer characterization of female cancers.
Keywords: Statistics, Laboratory medicine, Medical informatics, Cancer 
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Clinical proteomics and bioinformatics have spurred increased research in the 
ﬁeld of cancer biomarkers. The ideal biomarker would indicate both the presence 
of malignancy as well as the identity of the tissue of origin. We examined a panel 
of cytokines and cell adhesion molecules (CAM) using previously characterised 
biochip arrays in an attempt to identify breast and ovarian cancer speciﬁc proﬁles 
[1].
Cytokines are a diverse group of proteins comprised of hematopoietic growth 
factors, interferons, lymphokines, and chemokines [2]. Cytokines act as mediators 
of cell-to-cell communication. Uncontrolled cytokine expression contributes to: 
tumour growth and metastasis, immunosuppression and angiogenesis. Cytokine 
expression is not cancer speciﬁc and can be up-regulated during inﬂammation and 
wound repair [2]. CAMs are cell surface proteins involved in cell-to-cell and 
cell-to-extracellular matrix interactions. Altered CAM expression contributes to: 
tumour cell motility, tumour cell invasion and angiogenesis. CAM expression is not 
cancer speciﬁc and can be induced by cytokines [3].
Among women, breast cancer is the most commonly diagnosed cancer after 
non-melanoma skin cancer, and it is the second leading cause of cancer deaths after 
lung cancer. In 2015, an estimated 231,840 new cases will be diagnosed, and 
40,290 deaths from breast cancer will occur in the United States [4]. In American 
women, ovarian cancer is the ninth most common cancer, with an estimated 21,290 
new cases in 2015, but is the ﬁfth most deadly, with an estimated 14,180 deaths in 
2015 [4]. The availability of good biomarkers could assist in early detection, which 
in turn could contribute to improved prognosis.
Although expression of cytokines and CAMs is not cancer speciﬁc we set out to 
determine if there are breast and ovarian cancer speciﬁc cytokine and CAM plasma 
proﬁles. These proﬁles could then be leveraged to determine a patient’s cancerous 
tissue of origin. The random forest algorithm was used to address this question 
because it is resistant to over-ﬁtting, provides estimates of variable importance and 
generates a classiﬁer that can be applied to future data sets [5].
2. Methods
2.1. Samples and biochemical analysis
After ethics approval by the Hamilton Health Sciences research ethics board, 
EDTA plasma samples were obtained from cancer free women (𝑛 = 32; after 
informed consent), and the Ontario Tumour Bank (OTB), [1, 6]. All cases are liyon.2015.e00059
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Disease Progression
ND T0 T1 T2 T3 T4 TX
Breast 0 0 17 34 4 5 0
Healthy 32 0 0 0 0 0 0
Ovarian 0 3 10 8 17 0 4
pathologically veriﬁed and have clinical information, such as histology, patient 
history, and systemic therapy. The EDTA plasma samples obtained from the OTB 
were from women with a histological diagnosis of ovarian cancer (𝑛 = 42) or 
breast cancer (𝑛 = 60). Tumour staging (TNM system) of participants in this study 
is summarized in Table 1. Samples were measured for cytokines: IL-1 𝛼, IL-1 𝛽, 
IL-2, IL-4, IL-6, IL-8, IL-10, VEGF, MCP-1, EGF, TNF-𝛼, and IFN-𝛾 using the 
“Cytokine Array 1” and adhesion molecules: VCAM-1, ICAM-1, P-selectin, 
E-selectin, and L-selectin using the “Cell Adhesion Molecule Array” on the 
Evidence Investigator™ platform (Randox Ltd.). The analytical performance of 
these assays has been described previously [1].
2.2. Training the random forest algorithm
The patients were randomly assigned to the test (40%) or training (60%) data 
set. Random forest analysis of the training set was used to identify important 
variables for classiﬁcation of the test set (Figure 3). The random forest was trained 
to classify patient samples into one of four classes: breast cancer, ovarian cancer, 
cancer free or unknown based on the concentration of cytokines and cell adhesion 
molecules in the training set. The random forest procedure generated 1000 
bootstrapped classiﬁcation trees based on the training data set.
2.3. Classiﬁcation of the test data set
The random forest algorithm defaults to majority rules classiﬁcation. To 
improve diagnostic speciﬁcity a two part classiﬁcation rule was created for this 
study. Classiﬁcation thresholds were established based on the calculated 
probability of belonging to a given class and the highest threshold that did not 
reduce test eﬃciency was selected. This approach was taken to preserve test 
sensitivity where possible while optimizing speciﬁcity. Test eﬃciency was 
calculated as indicated in equation (1): where test eﬃciency (E), true positive (TP), 
true negative (TN), false positive (FP), false negative (FN).
𝐸 = TP + TN ⋅ 100 (1)
TP + TN + FP + FN
liyon.2015.e00059
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classiﬁcation threshold was incremented from 0–1 in steps of 0.001 (Figure 4). To 
maximize speciﬁcity the point with optimal eﬃciency and the highest probability 
threshold was selected as the classiﬁcation threshold (Table 3).
An “unknown” class was added to the algorithm for subjects that did not meet 
the classiﬁcation threshold of any other class. This permitted the following two part 
classiﬁcation rule for classiﬁcation of the test data set:
• Only the class with the highest probability was considered, this probability was 
then compared to the classiﬁcation threshold for that class.
• Samples with probability below the threshold were classiﬁed as “unknown”.
2.4. Software
All data analysis, and graphing was done using the R programming language [7]
and the random forest [8], boot [9], and ggplot [10] packages. R scripts are available 
for download at the following url: https :/ /github .com /hendersonmpa /chemokines.
3. Results
3.1. Analyte selection
The normalized distribution of cytokines and cell adhesion molecules in the 
study subjects is shown in Figure 2. The random forest method was applied to the 
training set and each variable was left out in succession to determine what impact 
that variable has on classiﬁcation accuracy. Subsequent analysis was performed 
using only analytes that contributed to classiﬁcation accuracy: TNF-𝛼, L-selectin, 
IL-1𝛼, P-selectin, IL-2, ICAM-1, IL-4, and VCAM-1 (Figure 3).
3.2. Classiﬁcation of the test data set
The optimal threshold probability was used to classify subjects from the test 
data set. The resulting predicted classes are presented in Figure 1 as parallel 
co-ordinates plots. In the parallel co-ordinates plots each line traces the probability 
of that individual belonging to the respective class: breast cancer, cancer free or 
ovarian cancer. The parallel co-ordinates plot for the breast cancer classiﬁcation 
shows that the random forest performs well, with most true positives far exceding 
the high threshold probability for classiﬁcation (Figure 1a). The errors in 
classiﬁcation occurred between ovarian cancer and cancer free classes, importantly liyon.2015.e00059
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Observed Predicted Error Adjusted
Breast Cancer free Ovarian Unknown
Breast 17 0 2 5 0.29 0.08
Cancer free 0 8 4 2 0.43 0.29
Ovarian 1 0 12 1 0.14 0.07
ndom Forest algorithm classiﬁcation accuracy using the optimal classiﬁcation threshold. 
rvals are provided. The asterisk indicates that intervals could not be calculated as there was no 
apped data sets.
Test (n) Threshold Eﬃciency Sensitivity 95% CI Speciﬁcity 95% CI
24 0.665 86.6 70.8 47.1–86.4 96.4 82.1–100
14 0.495 87.8 57.1 29.6–81.8 100.0 *–*
14 0.402 91.5 85.7 50–100 84.2 69.4–93.4
Figure 2. Boxplot summary of analyte concentration z-scores grouped by diagnosis: breast cancer (blue), 
healthy (green), and ovarian cancer (red).
no subjects with known cancer were assigned to the cancer free class. The cancer 
free class had no false positives, however, 4 cancer free subjects were classiﬁed as 
ovarian cancer (Figure 1b). Only two subjects were classiﬁed as unknown, both of 
which were cancer free. It is apparent from Figure 1 and Table 2 that the 
classiﬁcation was poorest for the cancer free subjects.liyon.2015.e00059
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in accuracy of 0.02 was used as a cut-oﬀ for inclusion (triangles) of the variable in subsequent analysis.
3.3. Classiﬁer performance
The performance of the classiﬁer on the test data set is presented in Table 3. The 
sensitivity and speciﬁcity of the classiﬁers with accompanying boot strapped 
conﬁdence intervals were calculated at the optimal probability thresholds. As 
expected given the classiﬁcation results (Table 2) the sensitivity for cancer free 
controls is poor while the other two classes have adequate sensitivity and 
speciﬁcity.
4. Discussion
In this study, we investigated whether cytokines and cell adhesion molecules 
exhibit distinct proﬁles in ovarian cancer, breast cancer and cancer free controls. 
Our results show that using the random forest classiﬁcation algorithm a panel of 
cytokines and cells adhesion molecules can distinguish between cancer free control 
subjects and those with ovarian and breast cancer with promising sensitivity and 
speciﬁcity.
The pathophysiological link between cytokines and cell adhesion molecules and 
cancer has been studied extensively [2, 3]. With the advent of multiplexed assays liyon.2015.e00059
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(red). Test eﬃciency was calulated for the training data at each vote threshold from 0 to 1 in increments 
of 0.001.
for these analytes, groups have begun investigating the diagnostic potential of these 
markers [1, 11, 12]. To date however no group has demonstrated more than 
bi-variate (health vs disease state) classiﬁcation. In practice, patients may present 
with uncertain tissue of origin therefore the three way classiﬁcation presented here 
represents a more challenging and realistic diagnostic situation.
The random forest algorithm allowed reﬁnement of the initial set of 17 potential 
markers down to 8 based on the markers contribution to classiﬁcation accuracy. 
The 8 selected markers: TNF-𝛼, L-selectin, IL-1𝛼, P-selectin, IL-2, ICAM-1, IL-4, 
and VCAM-1 contain both cytokines and cell adhesion molecules in equal 
frequency. Statistical analysis showed that although correlation of each of the 
above markers with each class was modest when combined via the random forest 
algorithm the panel showed very promising classiﬁcation eﬃciency.
Machine learning algorithms are easily applied to biochemical data sets with 
current statistical analysis software [13]. This may lead to undesirable classiﬁcation 
results. One example is the default majority rules classiﬁcation rule used by the 
random forest algorithm [5]. Applied naively the random forest algorithm will 
force each subject into one of the available classes. In this manuscript we modiﬁed 
the classiﬁcation algorithm to select highest threshold probability that preserved liyon.2015.e00059
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
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classify borderline subjects into an “unknown” class.
The classiﬁcation algorithm was most successful in subjects with ovarian cancer. 
This is encouraging as ovarian cancer is a challenging diagnosis relying on physical 
examination, imaging and ultimately a tissue diagnosis with tumour tissue obtained 
at the time of staging surgery. While this study is a promising proof of concept 
further studies with a larger and more diverse set of training data would allow 
classiﬁcation based on histologic subtypes of breast and ovarian cancer. The more 
homogeneous training classes will improve classiﬁcation. In addition, inclusion of 
recognized tumour markers such as carcinoembryonic antigen, CA-125, CA15-3, 
p53, HE4 and soluble HER2 will improve the utility of this classiﬁcation model.
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